Chimeric antigen receptor that binds HLA-DR and CAR-T cell
Byoung S. Kwon, Seoul (KR); Young Ho Kim, Seoul (KR); Kwang Hee Kim, Seoul (KR); Ji Won Chung, Seoul (KR); Young Gyoon Chang, Seoul (KR); Bo Rim Yi, Seoul (KR); Jung Yun Lee, Seoul (KR); Seung Hyun Lee, Seoul (KR); Sun Woo Im, Seoul (KR); Jin Kyung Choi, Seoul (KR); Hyun Tae Son, Seoul (KR); and Eun Hye Yoo, Seoul (KR)
Assigned to Eutilex Co., Ltd., Seoul (KR)
Filed by Eutilex Co., Ltd., Seoul (KR)
Filed on Mar. 1, 2021, as Appl. No. 17/188,011.
Application 17/188,011 is a division of application No. 16/715,462, filed on Dec. 16, 2019, granted, now 11,013,765, issued on May 25, 2021.
Application 16/715,462 is a continuation of application No. PCT/KR2019/010244, filed on Aug. 12, 2019.
Claims priority of provisional application 62/867,503, filed on Jun. 27, 2019.
Claims priority of provisional application 62/717,267, filed on Aug. 10, 2018.
Prior Publication US 2022/0031742 A1, Feb. 3, 2022
1. A nucleic acid molecule encoding an antigen binding molecule comprising a heavy-chain variable region of SEQ ID NO; 7 and a light-chain variable region of SEQ ID NO: 8, wherein the antigen-binding molecule is a chimeric antigen receptor (CAR).